Biological evaluation of compounds for their physical dependence potential and abuse liability. X. Drug testing programs of the Committee on Problems of Drug Dependence, Inc. (1986).
D015104:3,4-Methylenedioxyamphetamine / Q000031:analogs & derivatives; D000818:Animals; D001067:Appetite Depressants; D001952:Bridged-Ring Compounds / Q000009:adverse effects; D055598:Chemical Phenomena; D002621:Chemistry; D008621:Meptazinol; D018817:N-Methyl-3,4-methylenedioxyamphetamine; D009271:Naltrexone / Q000031:analogs & derivatives; D009294:Narcotics; D019966:Substance-Related Disorders
D001067:Appetite Depressants; D001952:Bridged-Ring Compounds; D009294:Narcotics; D008621:Meptazinol; D015104:3,4-Methylenedioxyamphetamine; D009271:Naltrexone; C054962:NIH 10366; C054963:NIH 10367; D018817:N-Methyl-3,4-methylenedioxyamphetamine; C038981:nalmefene